Exelixis (EXEL) Liabilities and Shareholders Equity (2010 - 2026)
Exelixis (EXEL) posted Liabilities and Shareholders Equity of $2.49 billion for Q2 2027, down 6.9% from $2.68 billion a year earlier and down 3.8% from the prior quarter.
Powered by 
Analysis
Exelixis (EXEL) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends
At the end of FY2026, Exelixis' Liabilities and Shareholders Equity came in at $2.84 billion, down 3.5% from FY2025.
- Annual Liabilities and Shareholders Equity shows a five-year compound annual growth rate of 1.7% (FY2021 to FY2026).
- In prior years, Exelixis' Liabilities and Shareholders Equity was $2.95 billion in FY2025, $2.94 billion in FY2023 (-4.2%) and $3.07 billion in FY2022 (+17.4%).
- The Q2 2027 figure stands as the lowest quarterly Liabilities and Shareholders Equity since Q3 2021.
- On a year-over-year basis, Liabilities and Shareholders Equity has declined in each of the last five quarters, with an average decline of 4.3% over the last six quarters.
- According to Business Quant data, Liabilities and Shareholders Equity for the three prior quarters was $2.59 billion (Q1 2027), $2.84 billion (Q4 2026) and $2.82 billion (Q3 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Exelixis | 14.54 Bn | 10.87 Bn | 608.03 Mn | 2.49 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 3, 2026 | 2.49 Bn |
| Apr 3, 2026 | 2.59 Bn |
| Jan 2, 2026 | 2.84 Bn |
| Oct 3, 2025 | 2.82 Bn |
| Jul 4, 2025 | 2.68 Bn |
| Apr 4, 2025 | 2.84 Bn |
| Jan 3, 2025 | 2.95 Bn |
| Sep 27, 2024 | 2.96 Bn |
| Jun 28, 2024 | 2.77 Bn |
| Mar 29, 2024 | 2.80 Bn |
| Dec 29, 2023 | 2.94 Bn |
| Sep 29, 2023 | 2.98 Bn |
| Jun 30, 2023 | 3.14 Bn |
| Mar 31, 2023 | 3.14 Bn |
| Dec 30, 2022 | 3.07 Bn |
| Sep 30, 2022 | 2.96 Bn |
| Jul 1, 2022 | 2.88 Bn |
| Apr 1, 2022 | 2.65 Bn |
| Dec 31, 2021 | 2.62 Bn |
| Oct 1, 2021 | 2.45 Bn |
API Access
Exelixis Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=EXEL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "EXEL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=EXEL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();